|
TAF7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.93240000024542E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.74607999999798E-05 |
| Normal-vs-Stage2 |
2.922500E-02 |
| Normal-vs-Stage3 |
1.74419999998676E-06 |
| Normal-vs-Stage4 |
3.87920000011199E-07 |
| Stage1-vs-Stage2 |
6.882800E-01 |
| Stage1-vs-Stage3 |
1.997400E-01 |
| Stage1-vs-Stage4 |
1.048980E-01 |
| Stage2-vs-Stage3 |
2.887200E-01 |
| Stage2-vs-Stage4 |
2.212800E-01 |
| Stage3-vs-Stage4 |
7.844800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.08900000000711E-05 |
| Normal-vs-AfricanAmerican |
2.770000E-02 |
| Normal-vs-Asian |
1.718390E-03 |
| Caucasian-vs-AfricanAmerican |
5.120800E-01 |
| Caucasian-vs-Asian |
9.218400E-01 |
| AfricanAmerican-vs-Asian |
6.213400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.7505999999965E-05 |
| Normal-vs-Female |
2.47840000000554E-06 |
| Male-vs-Female |
5.650800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.618300E-04 |
| Normal-vs-Age(41-60Yrs) |
3.69540000000335E-06 |
| Normal-vs-Age(61-80Yrs) |
4.48840000000228E-06 |
| Normal-vs-Age(81-100Yrs) |
4.586600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.589200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.853040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.821400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.268400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.329000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.985200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.967600E-02 |
| Classical-VS-Follicular |
7.961600E-02 |
| Classical-VS-Other |
9.221800E-01 |
| Classical-VS-Normal |
2.002100E-04 |
| Tall-VS-Follicular |
7.807400E-01 |
| Tall-VS-Other |
5.251600E-01 |
| Tall-VS-Normal |
2.28829999999736E-05 |
| Follicular-VS-Other |
5.208600E-01 |
| Follicular-VS-Normal |
3.76890000000074E-05 |
| Other-VS-Normal |
4.222600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.73210000001356E-06 |
| Normal-vs-N1 |
7.56150000391642E-08 |
| N0-vs-N1 |
5.599700E-02 |
|
|
